TransMedics Group, Inc.
TMDX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $3,827,417 | $4,544,637 | $2,268,816 | $2,094,487 |
| - Cash | $466,174 | $400,575 | $310,143 | $336,650 |
| + Debt | $519,349 | $518,822 | $518,410 | $518,287 |
| Enterprise Value | $3,880,592 | $4,662,884 | $2,477,083 | $2,276,124 |
| Revenue | $143,823 | $157,370 | $143,537 | $121,624 |
| % Growth | -8.6% | 9.6% | 18% | – |
| Gross Profit | $84,575 | $96,589 | $88,228 | $72,013 |
| % Margin | 58.8% | 61.4% | 61.5% | 59.2% |
| EBITDA | $33,371 | $46,389 | $36,274 | $16,240 |
| % Margin | 23.2% | 29.5% | 25.3% | 13.4% |
| Net Income | $24,319 | $34,907 | $25,682 | $6,857 |
| % Margin | 16.9% | 22.2% | 17.9% | 5.6% |
| EPS Diluted | 0.66 | 0.92 | 0.7 | 0.19 |
| % Growth | -28.3% | 31.4% | 268.4% | – |
| Operating Cash Flow | $69,573 | $91,609 | -$2,855 | $19,663 |
| Capital Expenditures | -$7,624 | -$9,075 | -$27,038 | -$13,606 |
| Free Cash Flow | $61,949 | $82,534 | -$29,893 | $6,057 |